Abstract
The prognosis of pancreatic cancer is very poor, 40%-50% of patients have liver metastasis at the time of initial diagnosis, and only 15%-20% of patients have the chance of surgical resection. At present, there is no consensus on the treatment strategy of pancreatic cancer with simultaneous liver metastasis. Surgeons are still looking forward to surgical resection for patients with longer survival time. The application of neoadjuvant therapy and radiofrequency ablation may bring new breakthroughs in the treatment of pancreatic cancer with simultaneous liver metastasis. This article reviews the surgical, neoadjuvant and palliative treatment of pancreatic cancer with simultaneous liver metastasis. Key words: Pancreatic neoplasms; Liver; Neoplasm metastasis; Treatment outcome; Simultaneity
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
